All News

A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.

The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed

The brain cancer vaccine SurVaxM is among the novel treatments currently being studied for patients with glioblastoma.

Suzanne Somers, who was known for her role on “Three’s Company,” died the day before her 77th birthday.

The Food and Drug Administration will speed up the review of odronextamab for patients with relasped or refractory follicular lymphoma or diffuse large B-cell lymphoma.

People-watching is one of my favorite activities.

Interim findings from the phase 2 ASPEN-06 clinical trial show evorpacept’s potential for treatment of patients with HER2-positive gastric/gastroesophageal junction cancer.

Tislelizumab demonstrated similar overall survival and safety in unresectable hepatocellular carcinoma compared with Nexavar, research found.

We’ve all heard the jokes about hospital food.

A new phase 1 trial is testing their first patients with STAR-LLD in the treatment of patients with multiple myeloma.

Fewer patients with chronic lymphocytic leukemia experienced cardiac toxicities with Calquence than those treated with Imbruvica, research showed.

Adding debulking surgery to chemotherapy did not cause a significant decrease in health-related quality of life for patients with metastatic colorectal cancer, research showed.

Adding TPST-1120 to the standard of care for the treatment of unresectable or metastatic hepatocellular carcinoma, a type of liver cancer, improved progression-free survival and overall survival in a phase 1b/2 clinical study.

Never underestimate your value to a person who has just been diagnosed. Isn’t that what these blogs are all about anyway?

From Julia Louis-Dreyfus opening up about her breast cancer experience to Dolph Lundgren discussing his experience, here’s what’s happening in the cancer space this week.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer resources for women of color with breast cancer that can help with emotional support throughout their journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to share ways patients can delegate tasks in order to take care of themselves during their cancer journey.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer background on what exactly resilience during breast cancer is.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to highlight the importance of having difficult conversations with one’s family about a breast cancer diagnosis and its treatment.

In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss mental resilience during one’s breast cancer journey.

Laura Shinn and Jenna Cavalero, both former childhood patients of the Children’s Hospital of New Orleans, reflect on how their cancer journeys inform their work with patients today.

Information about gynecologic cancers found on TikTok may not be credible or reliable, according to findings from a recent study.

In one of my favorite movies featuring Brad Pitt, the actor plays the role of Death, who comes to earth in human form.

While there has been a slight improvement in the availability of platinum-based chemotherapy agents, most institutions are still facing shortages and “living paycheck to paycheck” with the drugs, a survey revealed.

Survivors of cervical cancer who engage in sexual activity or vaginal dilation after radiation could be at lower risk for developing long term side effects.

Braftovi (encorafenib) with Mektovi (binimetinib) has been approved for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, the agency announced on Wednesday evening.

Adding BXCL701 to Keytruda tended to improve overall survival outcomes for patients with small cell neuroendocrine prostate cancer, according to phase 2 study results.

Findings from the CheckMate 649 trial “further support the use of (Opdivo) plus chemotherapy as a tolerable and efficacious first-line treatment” for some patients, according to researchers.

Exercise can help empower patients with cancer and boost their overall health, though on difficult days, it is equally important that patients give themselves grace, an expert said.